Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 9.00 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 9.00 | 9.50 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 318k | -11.17M | -0.0191 | -4.71 | 52.55M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 9.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 31/10/2024 | 13:00 | UKREG | e-therapeutics Announces Business Updates and Interim Results |
| 09/5/2024 | 06:00 | UK RNS | AIM Cancellation - e-Therapeutics Plc |
| 08/5/2024 | 06:00 | UK RNS | e-Therapeutics plc Last Day of Dealings on AIM |
| 03/5/2024 | 17:00 | UK RNS | FTSE Russell e-therapeutics |
| 29/4/2024 | 13:09 | UK RNS | e-Therapeutics plc Result of General Meeting |
| 10/4/2024 | 09:48 | ALNC |  e-Therapeutics says company faces lack of interest as UK listing |
| 10/4/2024 | 06:00 | UK RNS | e-Therapeutics plc Proposed Fundraise of £28.9m and Cancellation |
| 31/1/2024 | 16:30 | UK RNS | e-Therapeutics plc Total Voting Rights |
| 24/1/2024 | 10:04 | UKREG | e-Therapeutics plc Exercise of Options and Issue of Equity |
| 16/1/2024 | 10:34 | ALNC | IN BRIEF: e-Therapeutics shares rise on strong financial year |
E-therapeutics (ETX) Share Charts1 Year E-therapeutics Chart |
|
1 Month E-therapeutics Chart |
Intraday E-therapeutics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 04/11/2024 | 13:06 | E-Therapeutics ETX : Applying AI / ML to drug discovery & development | 1,018 |
| 13/9/2020 | 13:39 | ETX : Stocktube Vid | 75 |
| 13/9/2020 | 13:39 | ETX, The Boss & the Company | 3 |
| 13/9/2020 | 13:39 | ETX-Fighting MRSA & winning. | 1,095 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by E-therapeutics Daily Update E-therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 9p.E-therapeutics currently has 583,844,162 shares in issue. The market capitalisation of E-therapeutics is £52,545,975. E-therapeutics has a price to earnings ratio (PE ratio) of -4.71. This morning ETX shares opened at - |
Posted at 04/11/2024 11:59 by gnnmartin 1347, it's true that delisting is usually a prelude to folding or being taken over for pence, but the share price prior to delistng reflects that. I buy and hold shares until they succeed, or until the bitter end. Perhaps 25% of the companies fold, and a further 30% are in intensive care, but 20% or so do well enough to pay for the failures and give me something to live on as well.That said, I think the markets are very dangerous at the moment. Only the massive companies look safe, and money is pouring into them so their share prices are sky high and rising. Small companies and even medium sized companies are squeezed. If Trump gets in, goodness knows what will happen. The billionaires are de facto autocrats, and autocrats in the long run usually wreck a country (vide Putin, Erdogan, and possibly Xi). |
Posted at 04/11/2024 08:30 by 1347 As I said at the time I sold before the de-listing, there's too much risk and not enough progress. It's another company that suddendly 'forgets' about all it's past prospects and collaborations and heads off towards new rainbows (I noted in the last update they don't even get mentioned).Plus I wasn't going to repeat the experience with Deepmatter, where small investors got wiped out post delisting. There is no real market now so it's difficult to know a fair price and sell if you want to get out. Personally I now avoid anything where Griff has a significant stake, but each to their own hey. If it works out for you then fine but I don't 'invest' in companies that shaft small shareholders to the benefit of insiders. |
Posted at 03/11/2024 20:17 by 1347 Well maybe next time you ask them something maybe you should ask why their last CS01, filed just two weeks ago, stated there were no updates, despite a placing and subscription in April 2024. Do you know who holds what shares? Because it seems to me the shares are now held 60% by just two entities, who are in a position to take your shares off you at a price they chose, anytime, good luck with that, I hope it works out for you but I wouldn't trust this lot as far as I could throw them. |
Posted at 09/5/2024 12:09 by dplewis1 He owns 17% of Silence Therapeutics which has a market cap of over $1bn .. he doesn't give a monkeys what anyone on a share chat board says |
Posted at 12/4/2024 06:49 by 1347 Yes, good points. I'm not sure why any fund manager would say: I'll invest in a company but only if it's not listed? If you believe the company has serious prospects then what is the downside as an investor/fund manager to it being listed? Seems more to me that existing large shareholders prefer it to be unlisted as then there is less scrutiny. Makes you wonder eh?As for the NASDAQ listing, well the pre-cursor to that is usually an OTC listing, well they had that but then delisted at the end of 27 December 2023. They gave just 4 days notice over the Christmas/New Year period, so if there were many Americans interested in the company and taking a stake then they'll be hacked off I would imagine, as are the UK PIs now. As far as AI is concerned, well I can see the potential and it's a field I've worked in, but there's an awful lot of hype/rubbish being spouted about it at the moment, including by ETX I suspect. Ask yourself this, why have they only ever had a few contracts on the go paying relatively small milestone payments after all these years? Go and look at the last Business Update in January 2024 then look at what's happened since. By the way if you chose to hold then if it's anything like Deepmatter, which I suspect it will be as Griffin was behind both, then as a minority shareholder you are not going to get much, if anything, in the way of updates and so are very likely not going to realise what's going on until it's too late. I got just a few hours notice when they did the placing and consolidation at Deepmatter that wiped all but the biggest shareholders out. Personally after this behaviour I wouldn't touch anything Ali's involved in or Griffin is a large shareholder in with a bargepole, even if they discovered eternal life, but that's just my opinion, others should DYOR as they say. |
Posted at 12/4/2024 06:11 by pireric Very much agree with The Millipede/1347Nice excuse to complain that fund managers don't understand the potential risk reward in companies in this space. Most are serial destructors of shareholder value while management get paid richly. Hence they want to go to the US which seems all too happy to throw cash at ventures in the hope that one in 5/10 turns into a multibagger to justify the other failures. Or just to ride the coattails of US retail investors who are happy to pump and dump whatever the latest theme is If they really cared about investors they would have: 1) bought out the minorities or at least put a tender offer in place 2) evaluated a US listing mechanism while keeping ETX listed in the meantime Instead they are just annoying a large proportion of the retail shareholder base. Question around their fiduciary duty to force a bunch to sell at valuations which they self-believe are too low. Eric (no holding, never have) |
Posted at 11/4/2024 18:26 by the millipede Ali - I am not invested here and I don’t know what I would do in your shoes.Might depend on my time horizon. But note there is no promise at all of any future listing so if my horizon were not very long I think I would look to exit. As takeiteasy suggests this move is really about etx being able to raise more capital = more dilution, rather than necessarily any benefit for current shareholders. Silence’s share price has not risen at all since moving to Nasdaq (once you account for the 3:1 consolidation and exchange rate) and at times recently has in fact traded far lower. You are right to say the vote might not go through. Would be worth also checking with your broker about what would happen to your holding on delisting. This is not advice. I am here because I wondered briefly about buying some shares for my SIPP which I won’t need for a few decades. But having looked, I think I will pass. ATB and good luck, TM |
Posted at 11/4/2024 14:52 by the millipede Worth looking into the history of Silence Therapeutics, a previous firm run by Mortazavi. It delisted from AIM in 2021 and moved to Nasdaq.Currently the Nasdaq share price is lower than the price was on last day of AIM dealing. |
Posted at 11/4/2024 13:07 by gnnmartin When a share is delisted, the company usually arranges with a broker to enable trade of matched bargains. However, I don't think that is mandated, and anyhow it is a poor substitute for trading a listed share. That said, I've never actually used such a facility, so my criticism may be misplaced. |
Posted at 04/6/2020 17:14 by paulcon1 DP.....I agree but my initial reason for investing was the share price was at 2p, the MKt Value was 6-7 million (approx) and investors were taking advantage of Mr Woodford's misery... At 21.75p (week back) I thought ETX share price was in unchartered waters and needed a contract to justify the share price . Other posters disagreed... It is very difficult to place a price on potential and Intellectual Property.. That said, ETX, look to have great technology that could have game-changing possibilities, have a strong team and some wealthy investors seem to be very keen to hoover up shares. The more I read (and partially understand) the more impressed I am with their work and vision. I bought some shares at 17.25p today... The joys of investing!! GLA and IMHO |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
